• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-34促进纤维细胞增殖。

Interleukin-34 Promotes Fibrocyte Proliferation.

作者信息

Galligan Carole L, Fish Eleanor N

机构信息

1 Division of Advanced Diagnostics, Toronto General Hospital Research Institute, University Health Network , Toronto, Canada .

2 Department of Immunology, University of Toronto , Toronto, Canada .

出版信息

J Interferon Cytokine Res. 2017 Oct;37(10):440-448. doi: 10.1089/jir.2017.0063. Epub 2017 Oct 3.

DOI:10.1089/jir.2017.0063
PMID:28972432
Abstract

Rheumatoid arthritis (RA) is a systemic autoimmune disease affecting multiple joints. It remains unclear which factors in the circulation are associated with the systemic spread of the disease. Fibrocytes are pluripotent mesenchymal stem cells present in the circulation of RA patients. Our earlier findings implicated activated fibrocytes in the etiology of onset and pathogenesis of RA. Elevated levels of interleukin-34 (IL-34) in the serum and synovial fluid of RA patients are associated with rheumatoid factor and anticyclic citrullinated peptide antibodies, indicators of RA. Moreover, IL-34 levels are independent predictors of radiographic progression in RA patients. We provide evidence of simultaneous elevated levels of IL-34 and increased numbers of activated fibrocytes in the circulation of mice induced to develop arthritis. In vitro, IL-34 treatment induced the proliferation of fibrocytes, mediated by activation of cognate CSF-R1s on fibrocytes. Taken together, we infer that IL-34 has a role in stimulating fibrocyte proliferation and activation during arthritis, thereby contributing to both onset of RA and systemic spread of disease.

摘要

类风湿性关节炎(RA)是一种影响多个关节的全身性自身免疫性疾病。目前尚不清楚循环系统中的哪些因素与该疾病的全身扩散有关。纤维细胞是存在于RA患者循环系统中的多能间充质干细胞。我们早期的研究结果表明,活化的纤维细胞与RA的发病机制和病因有关。RA患者血清和滑液中白细胞介素-34(IL-34)水平升高与类风湿因子和抗环瓜氨酸肽抗体相关,这些都是RA的指标。此外,IL-34水平是RA患者影像学进展的独立预测指标。我们提供的证据表明,在诱导发生关节炎的小鼠循环系统中,IL-34水平同时升高,活化纤维细胞数量增加。在体外,IL-34处理通过激活纤维细胞上的同源CSF-R1介导纤维细胞增殖。综上所述,我们推断IL-34在关节炎期间刺激纤维细胞增殖和活化,从而导致RA的发病和疾病的全身扩散。

相似文献

1
Interleukin-34 Promotes Fibrocyte Proliferation.白细胞介素-34促进纤维细胞增殖。
J Interferon Cytokine Res. 2017 Oct;37(10):440-448. doi: 10.1089/jir.2017.0063. Epub 2017 Oct 3.
2
Fibrocyte and T cell interactions promote disease pathogenesis in rheumatoid arthritis.成纤维细胞与 T 细胞相互作用促进类风湿关节炎的发病机制。
J Autoimmun. 2016 May;69:38-50. doi: 10.1016/j.jaut.2016.02.008. Epub 2016 Mar 3.
3
Increased levels of interleukin 34 in serum and synovial fluid are associated with rheumatoid factor and anticyclic citrullinated peptide antibody titers in patients with rheumatoid arthritis.血清和滑液中白细胞介素 34 水平的升高与类风湿关节炎患者的类风湿因子和抗环瓜氨酸肽抗体滴度相关。
J Rheumatol. 2013 Nov;40(11):1842-9. doi: 10.3899/jrheum.130356. Epub 2013 Sep 1.
4
Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis.白细胞介素-21促进类风湿关节炎患者及胶原诱导性关节炎小鼠的破骨细胞生成。
Arthritis Rheum. 2012 Mar;64(3):740-51. doi: 10.1002/art.33390.
5
Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine.白细胞介素-22在类风湿关节炎中的表达:作为促炎细胞因子的潜在作用。
Arthritis Rheum. 2005 Apr;52(4):1037-46. doi: 10.1002/art.20965.
6
Interleukin-22 and rheumatoid arthritis: emerging role in pathogenesis and therapy.白细胞介素-22与类风湿关节炎:在发病机制和治疗中的新作用
Autoimmunity. 2015 Mar;48(2):69-72. doi: 10.3109/08916934.2014.959165. Epub 2014 Dec 8.
7
IL-34 Upregulated Th17 Production through Increased IL-6 Expression by Rheumatoid Fibroblast-Like Synoviocytes.白细胞介素-34通过类风湿性成纤维样滑膜细胞增加白细胞介素-6的表达上调辅助性T细胞17的产生。
Mediators Inflamm. 2017;2017:1567120. doi: 10.1155/2017/1567120. Epub 2017 Jun 4.
8
Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis.类风湿关节炎、银屑病关节炎和骨关节炎患者血清和滑液中白细胞介素(IL)-33 水平的差异。
Joint Bone Spine. 2012 Jan;79(1):32-7. doi: 10.1016/j.jbspin.2011.02.011. Epub 2011 Mar 26.
9
Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.白细胞介素(IL)-36α、β和γ、其拮抗剂IL-36Ra以及IL-38在银屑病、类风湿性关节炎和克罗恩病中的差异表达。
Clin Exp Immunol. 2016 May;184(2):159-73. doi: 10.1111/cei.12761. Epub 2016 Feb 22.
10
Circulating fibrocytes contribute to the pathogenesis of collagen antibody-induced arthritis.循环纤维细胞促成胶原抗体诱导性关节炎的发病机制。
Arthritis Rheum. 2012 Nov;64(11):3583-93. doi: 10.1002/art.34589.

引用本文的文献

1
Therapeutic IGF-I receptor inhibition alters fibrocyte immune phenotype in thyroid-associated ophthalmopathy.治疗性 IGF-I 受体抑制可改变甲状腺相关眼病中的成纤维细胞免疫表型。
Proc Natl Acad Sci U S A. 2021 Dec 28;118(52). doi: 10.1073/pnas.2114244118.
2
Cardiac and testicular alterations induced by acute exposure to titanium dioxide nanoparticles: Histopathological study.急性暴露于二氧化钛纳米颗粒引起的心脏和睾丸改变:组织病理学研究。
IET Nanobiotechnol. 2021 Feb;15(1):58-67. doi: 10.1049/nbt2.12000. Epub 2020 Dec 15.
3
IL-34 affects fibroblast-like synoviocyte proliferation, apoptosis and function by regulating IL-17.
IL-34 通过调节 IL-17 影响成纤维样滑膜细胞的增殖、凋亡和功能。
Sci Rep. 2021 Aug 12;11(1):16378. doi: 10.1038/s41598-021-95839-1.
4
The twin cytokines interleukin-34 and CSF-1: masterful conductors of macrophage homeostasis.双细胞因子白细胞介素-34 和 CSF-1:巨噬细胞动态平衡的卓越指挥者。
Theranostics. 2021 Jan 1;11(4):1568-1593. doi: 10.7150/thno.50683. eCollection 2021.
5
Fibrocytes, Wound Healing, and Corneal Fibrosis.成纤维细胞、伤口愈合和角膜纤维化。
Invest Ophthalmol Vis Sci. 2020 Feb 7;61(2):28. doi: 10.1167/iovs.61.2.28.
6
Autocrine Production of Interleukin-34 Promotes the Development of Endometriosis through CSF1R/JAK3/STAT6 signaling.自分泌产生的白细胞介素-34 通过 CSF1R/JAK3/STAT6 信号通路促进子宫内膜异位症的发展。
Sci Rep. 2019 Nov 14;9(1):16781. doi: 10.1038/s41598-019-52741-1.
7
Interleukin 30 to Interleukin 40.白细胞介素 30 至白细胞介素 40。
J Interferon Cytokine Res. 2018 Oct;38(10):423-439. doi: 10.1089/jir.2018.0089.